| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |